Navigation Links
Early Adopter of INFORM HER2 Dual ISH Assay Optimistic About Impact on Patient Care, Hospital Bottom Line
Date:9/12/2011

t cancer. This study showed that the test was effective in confirming that a patient's tumor sample contained more than the normal number of copies of the HER2 gene in 96 percent of the HER2-positive tumor samples. Patients with more than the normal number of HER2 gene copies are considered candidates for Herceptin therapy.

"HER2 by ISH method is the gold standard in determining HER2 amplification," says Dr. Erika Bracamonte, director of surgical pathology at UMC. "HER2 Dual ISH will allow our hospital to use our own lab, instruments and pathologists rather than outsourcing. ISH testing will be brought into the daily function of the laboratory, bringing additional revenue for the healthcare center. Overall, this product is a win-win-win for patients, clinicians and the hospital."

"Ventana and Roche are global leaders in companion diagnostics, including assays for predicting response to Herceptin," said Greg Yap, Ventana lifecycle leader for advanced staining assays. "FDA approval of the HER2 Dual ISH assay is an important milestone benefiting breast cancer patients and diagnostic providers in the U.S. The HER2 Dual ISH assay has been marketed outside the U.S. as a CE marked in vitro diagnostic since 2010 and has quickly become the market leader. Combined with our market-leading PATHWAY HER2 (4B5) immunohistochemistry assay and our complete suite of fully automated diagnostic solutions, Ventana continues to innovate and advance breast cancer testing."

About University Medical Center:

University Medical Center is a 487-bed hospital in Tucson, Arizona. It is the flagship teaching hospital of the University of Arizona College of Medicine. UMC is a national leader in heart care, oncology, organ transplantation, trauma and pediatrics and has earned a spot among US News & World Reports' Best Hospitals every year for more than a decade. Its mission is to advance health and wellness through education, research and patie
'/>"/>

SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SBRT for Medically Inoperable Early Stage Lung Cancer a Key Topic for Elekta Presenters at Lung Cancer Conference
2. Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food for Local Families
3. FDA Sets Meeting Date in Early June to Discuss Re-submission of Pixantrone NDA for Accelerated Approval
4. Life Technologies and ProBioGen AG Announce Freedom™ Cell Line Development Royalty-Free Kits To Advance Early Stage Biologic Drug Production
5. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
6. Early Diagnosis and Treatment the Focus of International Dialogue on Primary Immunodeficiency Disease
7. Phreesia Screening Tool Helps Physician Practices with Autism Early Detection
8. After the ABRF Conference: Gene Codes Flooded with Requests for Early Access to NextGen Software Tools
9. New Pneumococcal Vaccine Approach Successful in Early Tests
10. How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements
11. Reimbursement Rate Nearly Tripled for Cylexs ImmuKnow® Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... VIENNA , October 20, 2014 ... of gastrointestinal (GI) disorders and the delivery of care ... liver diseases and worrying inequalities in the provision of ... survey, which was commissioned by United European Gastroenterology (UEG), ... greater political and public awareness of the burden of ...
(Date:10/20/2014)... Earle Martin , Chief ... that Ellen Teplitzky, an experienced attorney specializing in ... industry, has joined the firm as Director of ... practice. NDA Partners provides legal services, including ... to top law firms and their clients in ...
(Date:10/19/2014)... Oct. 19, 2014 NextCODE Health, which enables clinicians ... in real time, today announced the launch of its new ... , at the American Society of Human Genetics (ASHG) annual ... more, sign up and apply for free beta access, visit ... and benefits can be viewed here . ...
(Date:10/19/2014)... The report "Chocolate, Cocoa Beans, Lecithin, Sugar and ... and Forecast (2011 - 2016)," analyzes the chocolate ... the major market drivers, restraints, and opportunities for the ... The global chocolate market is expected to grow from ... an estimated CAGR of 2.7% from 2011 to 2016. ...
Breaking Biology Technology:Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... ... capabilities for Mass Spectrometry-based biomarker discovery will be demonstrated at the 57th ASMS Conference ... Convention Center. , ... Philadelphia, PA (PRWEB) June 1, 2009 -- Genedata , a leading provider of ...
... , - Results Presented at American Society of Clinical ... Tolerated with Favorable Pharmacokinetics and Prolonged Stable Disease in ... 1 Mersana Therapeutics presented preliminary results of a ... XMT-1001, in a poster session at the 2009 Annual ...
... Webinar on June 9 to discuss the prevalence and prevention ... www.connecttoprotect.com - , , BETHESDA, ... (AGA) Institute and Horizon Therapeutics, Inc. today launched Connect ... gastrointestinal (GI) risks associated with the use of non-steroidal anti-inflammatory ...
Cached Biology Technology:Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities 2Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities 3Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 2Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 3AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 2AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 3
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or ... commerce market releases photos and video of the recent opening bell ... th . Gino Pereira , CEO of ... Mr. Chad A. Verdi rang the bell.  ... and employees "for their work and dedication in bringing the world,s ...
(Date:10/14/2014)... – Like discriminating thieves, prostate cancer tumors scavenge and ... body. But such avarice may be a fatal weakness. ... way to kill prostate cancer cells by delivering a ... destroys the diseased cells brimming with the mineral, leaving ... two drugs already commercially available for other uses, could ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Prostate cancer's penchant for copper may be a fatal flaw 2
... gene may be an early step in the development of ... this inactivation may ultimately be useful in risk assessment for ... 21 issue of the Journal of the National Cancer ... cells with a "field defect", cells that appear normal but ...
... Human Genome Research Institute (NHGRI), one of the National ... Sequencing Research Network will target 13 more organisms as ... that will expand biological knowledge and improve human health. ... (NACHGR), which is a federally chartered committee that advises ...
... Nanostructured micro-devices may be mass produced at a ... shapes and compositions than ever before, for dramatic ... biologically produced structures. These entirely new biologically-enabled approaches ... International Journal of Applied Ceramic Technology, published on ...
Cached Biology News:Change in gene may be underlying molecular defect in some colorectal cancers 2Possible treatment found for 'chemobrain' 2Possible treatment found for 'chemobrain' 3Possible treatment found for 'chemobrain' 4Possible treatment found for 'chemobrain' 5